Ciprofloxacin: Difference between revisions
From IDWiki
(Created page with "== Clinical Breakpoints == * For the Enterobacteriaceae changed recently ** MIC of 1 previously reported as susceptible but had reports of reduced susceptibility in pract...") |
No edit summary |
||
| Line 1: | Line 1: | ||
== Background == |
|||
* Fluoroquinolone antibiotic with [[Antipseudomonal antibiotics|antipseudomonal activity]] |
|||
* Inhibits [[Inhibits::CYP1A2]] |
|||
== Clinical Breakpoints == |
== Clinical Breakpoints == |
||
Latest revision as of 14:10, 23 September 2024
Background
- Fluoroquinolone antibiotic with antipseudomonal activity
- Inhibits CYP1A2
Clinical Breakpoints
- For the Enterobacteriaceae changed recently
- MIC of 1 previously reported as susceptible but had reports of reduced susceptibility in practice
- New cutoff is 0.5 for susceptibility
